财中社1月6日电药明巨诺-B(02126)发布公告,宣布于2025年1月6日根据首次公开发行后激励计划授出合共39万份购股权和7.8万个受限制股份单位,授予两名承授人。购股权的行使价为每股1.36港元,基于授出日期的收市价以及前五个营业日的平均收市价。购股权的行使期为2025年1月6日至2035年1月5日,归属开始日期为2024年7月1日。受限制股份单位的授出也于同日进行,授出日期股份收市价同样为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.